what is retatrutide UK 2026: Phase 3 Results Retatrutide - Wikipedia

Description Retatrutide is a triple-receptor agonist research peptide that simultaneously targets the GLP-1, GIP, and glucagon receptors three of the most significant metabolic signalling pathways in current endocrinology research

Importantly, with the advent of more potent GLP-1 receptor agonists like semaglutide, it is crucial to study these newer medications individually rather than grouping them with older drugs in the same class, as their effects may differ significantly, she added

Obesity, 21, 16021607

Prescription GLP-1 drugs work, but they require weekly injections and cost upward of $1,000 per month without insurance

Glucose homeostasis is also regulated by other glucoregulatory hormones like amylin, glucagon-like peptide-1 (GLP-1), gastric inhibitory polypeptide (GIP), epinephrine, cortisol, and growth hormone (GH)

This feeling of fullness can be unpleasant